The use of cyclodopamine or anti-Shh antibody to interfere with Shh-GLI pathway can inhibit the proliferation of primary prostate cancer culture of GLI+/PSA+, suggesting that this autocrine regulation of Shh signaling may be the key to maintain the growth of PCa 44. This evidence concerns the gene GLI1 and prostate carcinoma.